Thomas Hostetter

Thomas Hostetter, MD is Professor of Medicine at the University of North Carolina at Chapel Hill School of Medicine, Department of Medicine, Division of Nephrology and Hypertension. His career spans over four decades of research and clinical practice in nephrology.

Dr. Hostetter's primary research interests focus on the mechanisms and predictors of chronic kidney disease progression and the potentially toxic substances retained in kidney failure. His work has significantly contributed to understanding uremia, uremic toxins, diabetic nephropathy, and the pathophysiology of kidney disease progression. He has been instrumental in developing frameworks for understanding and classifying chronic kidney disease.

Analysis of Dr. Hostetter's extensive publication record reveals a consistent focus on uremic toxins and their clinical relevance, with particular emphasis on how these substances accumulate in kidney failure and contribute to systemic complications. His work bridges basic science with clinical practice, particularly in the areas of dialysis efficacy and the pathophysiological mechanisms underlying progressive kidney disease.

Dr. Hostetter has been actively involved in professional organizations and initiatives, including the American Society of Nephrology Public Policy Board, as evidenced by his participation in World Kidney Day 2011. His work with Kidney Disease: Improving Global Outcomes (KDIGO) has helped standardize the definition and classification of chronic kidney disease worldwide.

Throughout his career, Dr. Hostetter has made significant contributions to nephrology education and clinical practice guidelines. His research continues to influence how clinicians understand and manage chronic kidney disease and its complications, particularly regarding the accumulation and effects of uremic toxins in renal failure.